SA Locarnini
- Hepatology top 2%
- Infectious Diseases top 5%
- Epidemiology
- Cardiology and Cardiovascular Medicine top 10%
- Agronomy and Crop Science top 10%
- Co-authors
- Ian D. GustA G CoulepisAngeline BartholomeuszChristopher J. BirchF. A. LewisMargery KennettHui ZhuangDavid A. Anderson
- Topics
- Hepatitis B Virus Studies (11 papers)Hepatitis C virus research (8 papers)Hepatitis Viruses Studies and Epidemiology (7 papers)
- Partner nations
- AustraliaUnited States
In The Last Decade
SA Locarnini
19 papers receiving 397 citations
Peers
Comparison fields: 5 of 36
- Hepatology 293
- Infectious Diseases 265
- Epidemiology 187
- Cardiology and Cardiovascular Medicine 166
- Agronomy and Crop Science 45
Countries citing papers authored by SA Locarnini
This map shows the geographic impact of SA Locarnini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SA Locarnini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SA Locarnini more than expected).
Fields of papers citing papers by SA Locarnini
This network shows the impact of papers produced by SA Locarnini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SA Locarnini. The network helps show where SA Locarnini may publish in the future.
Co-authorship network of co-authors of SA Locarnini
This figure shows the co-authorship network connecting the top 25 collaborators of SA Locarnini. A scholar is included among the top collaborators of SA Locarnini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SA Locarnini. SA Locarnini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Inarigivir: a novel RIG-I agonist for chronic hepatitis B | 1 |
| 2 | Effective inhibition of cccDNA derived mRNA/viral antigens and tolerability with ARC-520 | 1 |
| 3 | 23 | |
| 4 | 29 | |
| 5 | Up-regulation of toll-like receptor expression in chronic hepatitis C: Correlation with circulating pro-inflammatory cytokine levels and hepatic necro-inflammatory activity | 2 |
| 6 | 1 | |
| 7 | 11 | |
| 8 | Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective [see comments] | 1 |
| 9 | Detection of duck hepatitis B virus replicative markers in primary cultures of bile duct epithelial cells | 0 |
| 10 | Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease | 31 |
| 11 | 3 | |
| 12 | 15 | |
| 13 | 63 | |
| 14 | 69 | |
| 15 | 21 | |
| 16 | 21 | |
| 17 | 1 | |
| 18 | A prospective study of acute viral hepatitis with particular reference to hepatitis A. | 31 |
| 19 | Enterovirus type 71 infection in Melbourne. | 98 |
| 20 | 6 |
About SA Locarnini
SA Locarnini is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 21 papers that have together received 438 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (11 papers), Hepatitis C virus research (8 papers) and Hepatitis Viruses Studies and Epidemiology (7 papers). The work is most often cited by research in Hepatology (293 citations), Infectious Diseases (265 citations) and Cardiology and Cardiovascular Medicine (166 citations). SA Locarnini has collaborated with scholars based in Australia and United States. Frequent co-authors include Ian D. Gust, A G Coulepis, Angeline Bartholomeusz, Christopher J. Birch, F. A. Lewis, Margery Kennett, Hui Zhuang, David A. Anderson, Fei Li and John G.R. Hurrell. Their work appears in journals such as The Lancet, Hepatology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.